Edesa Biotech EDSA
NASDAQ EDSA
$2.85 +0.03 (+1.06%)
At close: Oct 21, 2026 · 4:00 PM EDT

Edesa Biotech (EDSA) Current Deferred Revenue (2014 - 2019)

Updated

Edesa Biotech (EDSA) recorded Current Deferred Revenue of $80,000 in fiscal Q2 2020 (quarter ended Mar 31, 2019), unchanged from the prior quarter.

Analysis

Edesa Biotech (EDSA) Current Deferred Revenue (2014 - 2019) Analysis & Trends

At the end of FY2015 (ended Sep 30, 2015), Edesa Biotech reported Current Deferred Revenue of $173,333.

  • Across earlier fiscal years, Current Deferred Revenue came in at $15,000 in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Edesa Biotech 26.08 Mn -19.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 80,000.00
Dec 31, 2018 80,000.00
Jun 30, 2016 173,333.00
Mar 31, 2016 173,333.00
Sep 30, 2015 173,333.00
Jun 30, 2015 173,333.00
Dec 31, 2014 86,667.00
Aug 31, 2014 15,000.00
API Access

Edesa Biotech Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=EDSA&period=max&api_key=YOUR_API_KEY